Associations of a polymorphism in the ornithine decarboxylase gene with colorectal cancer survival

Clinical Cancer Research

Volumn 15, Issue 19, 2009, Pages 6208-6216

  Zell, Jason A ^a   Ziogas, Argyrios ^a   Ignatenko, Natalia ^b   Honda, Jane ^a   Qu, Ning ^c   Bobbs, Alexander S ^d   Neuhausen, Susan L ^a   Gerner, Eugene W ^c,e   Anton Culver, Hoda ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e Cancer Prevention Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORNITHINE DECARBOXYLASE; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; EXPRESSION VECTOR; FEMALE; FOLLOW UP; GENE ACTIVITY; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; ONCOGENE C MYC; OVERALL SURVIVAL; PRIORITY JOURNAL; PROMOTER REGION; REPRESSOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE; SURVIVAL TIME;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HCT116 CELLS; HT29 CELLS; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; ORNITHINE DECARBOXYLASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECURRENCE; SURVIVAL ANALYSIS;

EID: 70349673598     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-0592     Document Type: Article

References (33)

1. Wallace HM. The physiological role of the polyamines. Eur J Clin Invest 2000;30:1-3.
2. Gerner EW, Meyskens FL. Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer 2004;4:781-792 (Pubitemid 39331150)
3. Thomas T, Thomas TJ. Polyamine metabolism and cancer. J Cell Mol Med 2003;7:113-126
4. Giardiello FM, Hamilton SR, Hylind LM, Yang VW, Tamez P, Casero RA. Ornithine decarboxylase and polyamines in familial adenomatous polyposis. Cancer Res 1997;57:199-201. (Pubitemid 27036592)
5. Fultz KE, Gerner EW. APC-dependent regulation of ornithine decarboxylase in human colon tumor cells. Mol Carcinog 2002;34:10-18
6. Erdman SH, Ignatenko NA, Powell MB, et al. APC-dependent changes in expression of genes influencing polyamine metabolism, and consequences for gastrointestinal carcinogenesis, in the Minmouse. Carcinogenesis 1999;20:1709-1713
7. Martinez ME, O'Brien TG, Fultz KE, et al. Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene. Proc Natl Acad Sci U S A 2003;100:7859-7864
8. Bellofernandez C, Packham G, Cleveland JL. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc Natl Acad Sci U S A 1993;90:7804-7808 (Pubitemid 23250039)
9. Childs AC, Mehta DJ, Gerner EW. Polyamine dependent gene expression. Cell Mol Life Sci 2003;60:1394-1406
10. Love RR, Carbone PP, Verma AK, et al. Randomized phase I chemoprevention dose-seeking study of α-difluoromethylornithine. J Natl Cancer Inst 1993;85:732-737 (Pubitemid 23133595)
11. Gerner EW, Garewal HS, Emerson SS, Sampliner RE. Gastrointestinal tissue polyamine contents of patients with Barrett's esophagus treated with α-difluoromethylornithine. Cancer Epidemiol Biomarkers Prev 1994;3:325-330
12. Meyskens FL, Emerson SS, Pelot D, et al. Dose de-escalation chemoprevention trial of α-difluoromethylornithine in patients with colon polyps. J Natl Cancer Inst 1994;86:1122-1130 (Pubitemid 24249297)
13. Meyskens FL, Gerner EW, Emerson S, et al. Effect of α- difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention. J Natl Cancer Inst 1998;90:1212-1218 (Pubitemid 28407087)
14. Simoneau AR, Gerner EW, Phung M, McLaren CE, Meyskens FL, Jr. α-difluoromethylornithine and polyamine levels in the human prostate: results of a phase IIa trial. J Natl Cancer Inst 2001;93:57-59
15. Simoneau AR, Gerner EW, Nagle R, et al. The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIbr andomized placebo-controlled chemoprevention trial. Cancer Epidemiol Biomarkers Prev 2008;17:292-299 (Pubitemid 351272778)
16. Meyskens FL, McLaren CE, Pelot D, Fujikawa-Brooks S, et al. Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res (Phila Pa) 2008;1:32-38
17. Barry ELR, Baron JA, Bhat S, et al. Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention. J Natl Cancer Inst 2006; 98:1494-1500 (Pubitemid 44605594)
18. Hubner RA, Muir KR, Liu JF, Logan RF, Grainge MJ, Houlston RS. Ornithine decarboxylase G316A genotype is prognostic for colorectal adenoma recurrence and predicts efficacy of aspirin chemoprevention. Clin Cancer Res 2008;14: 2303-2309
19. Visvanathan K, Helzlsouer KJ, Boorman DW, et al. Association among an ornithine decarboxylase polymorphism, androgen receptor gene (CAG) repeat length and prostate cancer risk. J Urol 2004;171:652-655 (Pubitemid 38090449)
20. Ignatenko NA, Holubec H, Besselsen DG, et al. Role of c-Myc in intestinal tumorigenesis of the ApcMin/+ mouse. Cancer Biol Ther 2006;5:1658-1664 (Pubitemid 46256645)
21. Peel DJ, Ziogas A, Fox EA, et al. Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases. J Natl Cancer Inst 2000;92:1517-1522 (Pubitemid 30757425)
22. Zell JA, Ignatenko NA, Yerushalmi HF, et al. Risk and risk reduction involving arginine intake and meat consumption in colorectal tumorigenesis and survival. Int J Cancer 2007;120:459-468
23. Zell JA, Honda J, Ziogas A, Anton-Culver H. Survival after colorectal cancer diagnosis is associated with colorectal cancer family history. Cancer Epidemiol Biomarkers Prev 2008;17:3134-3140
24. Le H, Ziogas A, Lipkin SM, Zell JA. Effects of socioeconomic status and treatment disparities in colorectal cancer survival. Cancer Epidemiol Biomarkers Prev 2008;17:1950-1962
25. Ziogas A, Anton-Culver H. Validation of family history data in cancer family registries. Am J Prev Med 2003;24:190-198 (Pubitemid 36144098)
26. Guo YJ, Harris RB, Rosson D, Boorman D, O'Brien TG. Functional analysis of human ornithine decarboxylase alleles. Cancer Res 2000; 60:6314-6317 (Pubitemid 30952130)
27. Iwamoto M, Ahnen DJ, Franklin WA, Maltzman TH. Expression of β-catenin and full-length APC protein in normal and neoplastic colonic tissues. Carcinogenesis 2000;21:1935-1940 (Pubitemid 30843725)
28. O'Brien TG, Guo Y, Visvanathan K, et al. Differences in ornithine decarboxylase and androgen receptor allele frequencies among ethnic groups. Mol Carcinog 2004;41:120-123 (Pubitemid 39336761)
29. Derynck R, Akhurst RJ, Balmain A. TGF-β signaling in tumor suppression and cancer progression. Nat Genet 2001;29:117-129 (Pubitemid 32952643)
30. Pardali K, Moustakas A. Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta 2007; 1775:21-62. (Pubitemid 44881193)
31. Roberts AB, Wakefield LM. The two faces of transforming growth factor β in carcinogenesis. Proc Natl Acad Sci U S A 2003;100: 8621-8623 (Pubitemid 36899145)
32. Matsubara N, Hietala OA, Gilmour SK, et al. Association between high levels of ornithine decarboxylase activity and favorable prognosis in human colorectal carcinoma. Clin Cancer Res 1995;1:665-671
33. Babbar N, Gerner EW, Casero RA, Jr. Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cells. Biochem J 2006;394:317-324